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Abstract
Background: Pediatric pulmonary hypertension (PH) remains a disease with high morbidity and mortality in children.
Understanding ventricular-vascular coupling, a measure of how well matched the ventricular and vascular function are,
may elucidate pathway leading to right heart failure. Ventricular vascular coupling ratio (VVCR), comprised of effective
elastance (Ea, index of arterial load) and right ventricular maximal end-systolic elastance (Ees, index of contractility), is
conventionally determined by catheterization. Here, we apply a non-invasive approach to determining VVCR in
pediatric subjects with PH.
Methods: This retrospective study included PH subjects who had a cardiovascular magnetic resonance (CMR)
study within 14 days of cardiac catheterization. PH was defined as mean pulmonary artery pressure (mPAP)≥
25 mmHg on prior or current catheterization. A non-invasive measure of VVCR was derived from CMR-only (VVCRm)
and compared to VVCR estimated by catheterization-derived single beat estimation (VVCRs). Indexed pulmonary
vascular resistance (PVRi) and pulmonary vascular reactivity were determined during the catheterization procedure.
Pearson correlation coefficients were calculated between PVRi and VVCRm. Receiver operating characteristic (ROC)
curve analysis determined the diagnostic value of VVCRm in predicting vascular reactivity.
Results: Seventeen subjects (3 months-23 years; mean 11.3 ± 7.4 years) were identified between January 2009-August
2013 for inclusion with equal gender distributions. Mean mPAP was 35 mmHg ± 15 and PVRi was 8.5 Woods unit x
m2 ± 7.8. VVCRm (range 0.43–2.82) increased with increasing severity as defined by PVRi (p < 0.001), and was highly
correlated with PVRi (r = 0.92, 95 % CI 0.79–0.97, p < 0.0001). Regression of VVCRm and PVRi demonstrated differing lines
when separated by reactivity. VVCRm was significantly correlated with VVCRs (r = 0.79, CI 0.48–0.99, p <0.0001). ROC
curve analysis showed high accuracy of VVCRm in determining vascular reactivity (VVCR = 0.85 had a sensitivity of
100 % and a specificity of 80 %) with an area under the curve of 0.89 (p = 0.008).
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Conclusion: Measurement of VVCRm in pediatrics is feasible. Pulmonary vascular non-reactivity may be contribute to
ventricular-vascular decoupling in severe PH. Therapeutic intervention to maintain a low vascular afterload in reactive
patients may preserve right ventricular functional reserve and delay the onset of RV-PA decoupling. Use of VVCRm may
have significant prognostic implication.
Keywords: Ventricular vascular coupling ratio, Non-invasive, Pediatrics, Pulmonary hypertension, Cardiovascular
magnetic resonance
Background
Pulmonary hypertension (PH) in children remains an in-
curable disease with poor long-term prognosis that
crosses all racial and socioeconomic backgrounds [1].
PH affects both adults and children, with an annual inci-
dence of adult PH estimated to be 50 per million [2] and
pediatric PH estimated to be 63 per million [3]. While
there are some similarities between adult and pediatric
pathophysiology [4], the disease may be more severe
with worse survival in children [5–7]. This higher sever-
ity in youth is in due to differences in underlying causes,
presence of congenital heart disease, effects of matur-
ation, and differences in clinical symptoms leading to
diagnosis in later stages [8]. Different from adult PH, the
etiology of pediatric PH is mostly idiopathic pulmonary
arterial hypertension and PH associated with congenital
heart disease [1]. The main cause of mortality is failure
of the right ventricle (RV), which is the result of multi-
factorial interactions including the increase of arterial re-
sistance, pressure, and stiffness with the decoupling of the
ventricular-vascular system. Yet, in clinical practice, pul-
monary vascular resistance (PVR) is the primary focus for
the clinicians. Recently, there has been increased interest
in a more comprehensive understanding of the interaction
of the RV and vasculature, and the role that this inter-
action plays in the pathophysiology of PH [9–12].
The ventricular-vascular coupling ratio (VVCR), the
ratio of contractility to afterload, reflects the ventricular
functional reserve in response to a rising afterload in
order to maintain cardiac output. VVCR has been re-
cently shown to be prognostic of impending RV failure
[10]. Conventionally, VVCR is laboriously determined
invasively, in the cardiac catheterization laboratory with
the establishment of the pressure-volume loop under
varying loading conditions and clamping of the inferior
vena cava [6]. This can also be estimated via cathe-
terization using a single beat method without altering
preload or afterload, which has been validated for the
left [13, 14] and right ventricle [15]. Recently, Sanz et al.
[10] proposed using cardiovascular magnetic resonance
(CMR) to estimate VVCR. The authors show that an es-
timation of VVCR is feasible solely with noninvasive
volumetric data from CMR. Recently, Vanderpool et al.
showed that this approach, applied to adults with PH, is
a predictor of survival [12].
In this study, we apply Sanz’s approach to the pediatric
population with PH to determine VVCR in the right heart
and compare it to the modified single beat method. Deter-
mining the VVCR by noninvasive measures is critical in
the pediatric population. The lack of exposure to radi-
ation, anesthesia, and intracardiac catheter manipulations
with CMR are important concerns to consider, as these
patients often undergo multiple catheterization proce-
dures throughout their lives to establish diagnosis and
monitor responses to medications. As a result, the aims of
this study are to: 1) determine if the noninvasive CMR ap-
proach to VVCR determination is feasible in a pediatric
population, 2) understand how the technique compares
with the more established single beat estimation method,
and 3) determine the ability of the CMR-based VVCR
method to predict patient outcome, as measured by acute
vasoreactivity.
Method
The medical records of children cared for in the Pulmonary
Hypertension Program at Children’s Hospital Colorado
were retrospectively reviewed from January 2009 to
August 2013 for any patient, age 0 days to 65 years, who
underwent a right heart catheterization (RHC) for pul-
monary hypertension. The diagnosis of PH is defined by a
previous or present cardiac catheterization showing mean
pulmonary artery pressure (mPAP) ≥ 25 mmHg. Two hun-
dred and forty-two patients were identified. Of these, we
identified seventeen subjects who had a CMR study per-
formed within 14 days of a cardiac catheterization. Ex-
clusion criteria were: 1) pulmonary valve or pulmonary
arterial stenosis; 2) previous surgical or catheterization
intervention on the pulmonary valve or pulmonary artery;
3) pulmonary artery stenosis 4) previous right ventricu-
lotomy; 5) congenital heart disease more complex than
simple atrial septal defect; 6) more than mild pulmonary
insufficiency; 7) severe left-sided obstruction that can po-
tentially cause elevated pulmonary pressures; 8) chronic
thrombolic pulmonary hypertension and 9) presence of
arrhythmias. We excluded anatomic stenosis of the pul-
monary circulation and chronic thrombolic PH because
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this is a study of vascular remodeling in the presence of
high resistance rather than a study of the effects of ana-
tomic constrictions or obstruction to flow. This study was
carried out with the approval of the Colorado Institutional
Review Board.
Determination of VVCR
VVCR is composed of the arterial elastance (Ea, repre-
senting afterload encountered by the ventricle and is a
combination of resistance, compliance, and the time
interval between systole and diastole) and the right max-
imal end-systolic elastance (Ees, reflecting the index of
ventricular contractility) [10]. In adults with PH, VVCR
has been shown to be significantly increased [10]. Ele-
vated VVCR reflects an inability of the RV function to
compensate for an increasing pulmonary arterial load
and thus results in mechanical inefficiency, leading to
RV failure. This state is the early stages of ventricular-
vascular decoupling, when cardiac mechanic efficiency
declines in the face of a significant afterload.
VVCR by CMR
CMR studies were performed either on a 1.5 Tesla
Siemens Avanto (Siemens Medical Solutions, Erlanger,
Germany) or a 1.5 Tesla Philips Achieva (Philips Medical
Systems, Best The Netherlands) scanner. Five of the
youngest subjects were sedated for the CMR. Standard
horizontal long axis and short axis images were obtained
at end-expiration with a parallel stack of serial images
acquired from the base to the apex [16]. Depending on the
size of a subject, the parameters ranged from slice thick-
ness of 4–10 mm, number of averages 1–3, TE 1.1–1.5,
TR 2.8–3.5, and in-plane resolution 1.2–1.4 mm. Volumes
were measured on Qmass software (MEDIS Medical
Imaging Systems, Leiden, The Netherlands) by manually
tracing the endocardial border at end diastole and end-
systole. From this, data including end-systolic volume
indexed to BSA, stroke volume indexed to BSA, and ejec-
tion fraction were calculated. Sanz’s approach was used to
calculate VVCRm ¼ ESVSV [10]. RV ejection fraction is cal-
culated as the difference in volume at end-diastole and
end-systole, all over the end-diastolic volume × 100.
VVCR by single beat estimation
Right heart catheterization All subjects were under
general anesthesia for the RHC. A balloon-wedge cath-
eter was introduced through the femoral vein or internal
jugular vein and advanced into the right heart employing
standard methodologies. Hemodynamic measurements
were obtained, including right ventricular end-diastolic
pressure, mPAP, transpulmonary gradient, and PCWP
pressures. The Fick equation, with cardiac index calculated
as cardiac output divided by body surface area, was used
to determine cardiac output. PVR was calculated as the
difference between mPAP and PCWP, all divided by the
cardiac index. Indexed PVR is the product of PVR and
body surface area. Part of the standard PH right heart
catheterization at our institution is the determination of
vascular reactivity with data obtained at room air and
under vasodilator challenge. The vasodilator challenge in-
volves 80–100 % oxygen or oxygen + inhaled nitric oxide
(low dose: 20/40 ppm provided in the inhaled form). Vas-
cular reactivity was determined by the Barst criteria [17],
defined as
a) Decrease in mPAP of ≥ 20 %,
b) Unchanged or increased cardiac index, and
c) Decreased or unchanged PVR to systemic vascular
resistance ratio.
Single beat estimation
Once RV pressure traces were successfully acquired,
analysis was performed using a custom MATLAB (The
Mathworks, Natick, MA) to yield VVCRs. The single
beat method was first proposed by Takeuchi et al. [14]
in which the authors proposed a novel method for the
calculation Ees using the pressure tracing for a single
beat. In this method, the theoretical maximum pressure
the ventricle can generate is found by fitting a sinusoid
to the iso-volumetric regions of the pressure tracing.
The maximum of the sinusoid (Pmax) is used with the
end-systolic ventricular pressure (Pes) to compute the
slope of the end-systolic pressure volume relationship,
Ees. (Fig. 1). This method has been validated for the
right ventricle as well [15].
We modified this technique even further. Closely





Further given the definition [18, 19]
Ea ¼ PesSV ; ð2Þ












Thus, equation (3) approximates VVCRs as a simple
ratio of the inverse of maximum isovolumic pressure to
end-systolic pressure.
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Statistics
Statistical analysis was performed using the Statistical
Analysis System (version 9.3; SAS Corporation, Cary,
NC). Data were evaluated for normality using a Shapiro-
Wilk test. Normally distributed, continuous data are pre-
sented as mean with standard deviation and categorical
variables are presented as frequencies and percentages.
Regression analysis was performed to estimate the
relationship between VVCRm and PVRi. In addition,
Pearson correlation coefficients were calculated to deter-
mine strength of the relationship. Receiver-operating
characteristic (ROC) curve analysis was used to deter-
mine the cut-off value of VVCRm that was most fre-
quently associated with pulmonary vascular reactivity,
determined by the Barst criteria. This cut-off value max-
imizes the sum of sensitivity and specificity, which is
equivalent to maximizing the difference between the
sensitivity of the prognostic factor and the sensitivity
that the prognostic factor would have if it did no better
than random chance. Statistical significance was set at a
p-value of 0.05 or less.
Results
Seventeen subjects were identified for inclusion with
equal gender distributions (Table 1). Age ranged from
3 months to years (mean 11.3 ± 7.4 years). The following
diagnoses were noted for the subjects: 5 had idiopathic
PH, 6 had PH associated with congenital heart disease, 1
associated with liver arteriovenous malformation, 1
associated with anthracycline, 1 associated with schisto-
somiasis, 2 with interstitial lung disease, and 1 with pul-
monary hypertension associated with Overlap syndrome.
Ten out of 17 subjects, who were old enough to have a
World Health Organization (WHO) Functional Classifi-
cation, were characterized by WHO class I or II. Six out
of 17 subjects were on intravenous therapy. The
National Institute of Health defines a child as an indi-
vidual under 21 years of age.[20] We had only one
subject above age 20 years. This particular subject was
initially diagnosed at age 18 months with idiopathic PH
and has been followed by our group since 13 years of
age. Although the age at which he underwent the
catheterization and CMR was as a young adult, his dis-
ease is consistent with childhood pulmonary hyperten-
sion. Eighty-two percent of the subjects had tricuspid
regurgitation graded as none to mild based on echo-
cardiograms performed within 5 days of the cardiac
catheterization. Only one subject had severe tricuspid
regurgitation.
VVCRm and disease severity
VVCRm ranged from 0.84 to 3.29. While regression of
VVCRm and PVRi showed a linear relationship, a dif-
ference was seen in the slopes of the relationship be-
tween those who were reactive and those who were non-
reactive (Fig. 2).
VVCRm and VVCRs
VVCRs ranged from 1.25 to 2.4. VVCRm was found to
be significantly correlated with VVCRs (r = 0.79, CI
0.48–0.99, p <0.0001) (Fig. 3). Heart rates were not sig-
nificantly different during the catheterization compared
to the MRI (92.2 bpm ± 26.8 vs 89.2 bpm ± 24.2, respect-
ively; p = 0.7).
VVCR and clinical outcome
Receiver operating characteristic curve analysis (Figs. 3
and 4) revealed high accuracy of the VVCRm in deter-
mining vascular reactivity. VVCRm of 0.85 had a sensi-
tivity of 100 % and a specificity of 80 %. The area under
the curve is 0.89 (p = 0.008), suggesting good discrimin-
ation between those who were and were not reactive.
Table 2 describes the demographic features as well as
the MRI data between subjects who had acute vascular
reactivity. Subjects who showed positive reactivity were
younger, with lower RVEDVi, as well as VVCRm. In
addition, the median WHO-FC was 2 for the reactive
subjects, and 3 for the non-reactive subjects. PVRi was
not statistically significantly different, although the mean
PVRi among the non-reactive subjects was more than
Fig. 1 This diagram shows the single beat method by depicting how Ees and Ea are determined using the maximal pressure (Pmax) as the peak of
the sinusoid of a ventricular pressure tracing, end-systolic point (Pes), and (volume at end-diastole) Ved
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double that of the reactive subjects. Similarly, although
the length of disease was not statistically different be-
tween the two groups, the mean duration among the
non-reactive subjects was almost twice that of the re-
active subjects.
Discussion
In this paper, we have shown that the measurement of
VVCR by CMR data in children is feasible. Furthermore,
our study shows that VVCR derived from CMR data
correlates with VVCR derived from the single beat esti-
mation from catheterization-derived pressure tracings.
The most intriguing finding here is the potential of non-
invasively derived VVCR in predicting vasoreactivity.
Acute vasoreactivity have been shown to independently
predict transplant-free survival [21].
Table 1 Demographic, hemodynamic, and cardiac magnetic
resonance data for all subjects




BSA (m2) 1.2 ± 0.5
Pulmonary Hypertension Classificationa
1. Pulmonary arterial hypertension 15
1.1 Idiopathic 5
1.3 Drug and Toxin-induced (anthracycline) 1
1.4.1 Connective tissue disorder
(Overlap syndome)
1
1.4.3 Portal hypertension 1
1.4.4 Congenital heart disease 6
Atrial septal defect 4







3. Pulmonary hypertension due
to lung disease
2






Systolic pulmonary artery pressure (mmHg) 54.5 (20.6)
Diastolic pulmonary artery pressure (mmHg) 25.4 (11.7)
Mean pulmonary artery pressure (mmHg) 35 (15)
Pulmonary capillary wedge pressure (mmHg) 10.8 (3.2)
Pulmonary vascular resistance index
(Woods unit x m2)
8.5 (7.8)
Cardiac output indexed (L/min/m2) 4.8 (1.5)
Right ventricular volume
End-diastole (ml/m2) 118.4 (51.1)
End-systole (ml/m2) 70.9 (42.9)
Right ventricular ejection fraction (%) 46.6 (9.7)
Right ventricular stroke volume indexed (ml/m2) 54.4 (12.7)
Ea (mmHg/ml/m2) 0.49 (0.26)
Emax (mmHg/ml/m2) 0.56 (0.18)
VVCRs 1.79 (0.34)
VVCRm 1.29 (0.72)
aPulmonary hypertension classification based on 5th World Symposium in Nice,
France in 2013 from Simommeau G et al. Updated clinical classification of
pulmonary hypertension. JACC 2013:62:D34-41
Fig. 2 Regression of ventricular vascular coupling ratio derived by
MRI (VVCRm) and pulmonary vascular resistance indexed by reactivity.
The shaded areas represent the 95 % confidence interval for each
regression line. The lines depict different trajectories based on reactivity,
which approached, but not reach statistical significance (p > 0.05)
Fig. 3 Scatterplot showing a positive linear relationship between
ventricular vascular coupling ratio obtained by MRI compared to
that obtained by single beat method
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In the normal RV-PA axis, VVCR values range from
0.5 to 1.0, with the optimal ratio being 0.5 to 0.7 [22].
VVCR is significantly higher in the presence of PH.5
Fourie et al showed in invasive swine models that the
RV at resting state operates at maximal efficiency when
Ees > Ea. In this state, the maximum stroke work is ac-
complished by minimum oxygen consumption [9]. The
authors surmise that the RV maintains its reserve and
contractility until Ea > Ees and stroke volume begins to
fall. The concept of ventricular vascular coupling is
essential to understanding PH, since this disease exem-
plifies the breakdown of the complex interaction be-
tween the vasculature and ventricle, ultimately resulting
in RV failure. However, in clinical medicine, PVR con-
tinues to be primary parameter in which PH state is
accessed. This is due to the labor-intensive, invasive
nature of determining VVCR by establishing pressure-
volume loops. Sanz proposed a non-invasive approach to
determine VVCR based on CMR data [10]. Soon after
this publication, Trip et al. contended that the assump-
tion of a negligible volume at zero pressure, does not ac-
curately assess Ees when using the Sanz’ approach [11].
Although we agree that the Sanz approach based on only
CMR data may not be accurate, the benefit of a non-
invasive approach to estimate the VVCR is an extremely
valuable tool to serially follow PH patients over the
course of their lifetime. This is particularly vital in our
pediatric population since CMR avoids exposure to re-
peated radiation and decreases the need for general
anesthesia. In Sanz’s data, there is a curvilinear relation-
ship between VVCRm and PVR. In contrast, our data
shows a linear relationship. This may simply due to our
small patient population. Both Sanz’s and our data covers
a large range of PVRi, but with a significant sample differ-
ence of 150 in Sanz’s study compared to our 17 subjects.
In our study, the differences between the reactive and
non-reactive subjects are significant. Not surprisingly,
the PVRi trended towards higher values, and the
RVEDVi and VVCRm were higher among the non-
reactive subjects. The median WHO-FC was also higher
in this group. These parameters indicate a more severe
disease status among the non-reactive children and thus,
points to movement towards an uncoupled state. The
non-reactive group is also significantly older with a
trend towards having PH diagnosis for a longer time
period, reflecting the progressive nature of PH. The
slope of the line for the reactive patients is smaller than
for non-reactive. This suggests that RV functional re-
serve is relatively preserved. Therefore, these children
are able to accommodate an increase in afterload. How-
ever, the large slope in the non-reactive patients suggests
that they are in the maladaptive remodeling phase and
can no longer accommodate an increase in afterload.
Fig. 4 Receiver operating characteristic curve. Receiver operating
characteristic curve demonstrates an optimal threshold ventricular-
vascular coupling ratio (VVCR) of 0.85. Using this criterion, VVCR is
associated with a sensitivity of 100 % and a specificity of 80 % in
determining pulmonary reactivity
Table 2 Demographic data for reactive versus non-reactive
subjects






Age (years) 17 ± 4.1 8.5 ± 5.1 0.006
Female:male 4:2 4:4
Length of disease (years) 10.3 ± 6 5.7 ± 3.8 0.1
Pulmonary hypertension classification
1. Pulmonary arterial hypertension 6 6
1.1 Idiopathic 1 3
1.3 Drug and toxin-induced 1
1.4.1 Connective tissue disorder 1




3. Pulmonary hypertension due
to lung disease
2
PVRi (Woods unit x m2) 13.8 ± 11 6.1 ± 2.7 0.08
RVEDVi (ml/m2) 162 ± 61 100 ± 25 0.02
RVEF (%) 40 ± 14 50 ± 2.9 0.07
VVCRm 1.8 ± 1.0 1.0 ± 0.11 0.04
Abbreviations: PVRi pulmonary vascular resistance indexed, RVEDVi right
ventricular end-diastolic volume indexed, RVEF right ventricular ejection fraction
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Future studies of the pediatric population and break-
down of etiologies will enhance the understanding of PH
phenotypes.
VVCRm is related to RV ejection fraction [10], which
has been shown to predict mortality in adults [21, 23, 24].
However, there is currently no data in children on the re-
lationship between RV ejection fraction and outcomes,
catheterization data, or VVCR by the single beat method.
Furthermore, while RV ejection fraction describes only
ventricular systolic function, VVCR describes both the
status of the vasculature and the ventricular efficiency in
response to the changing afterload. Therefore, VVCR, and
not RV ejection fraction, can discriminate changes in
myocardial performance versus arterial load.
Limitations of this study include those inherent to a
retrospective study. While the separation of 14 days be-
tween cardiac catheterization and CMR is longer than
ideal, the infrequency of these two procedures being
performed during a close time period for clinical care
necessitated expanding our time frame; albeit 15/17 of
the subjects had the procedures performed within 48 h
of one another. We also recognize that the same patient
may have had the cardiac catheterization performed
under anesthesia while being awake for the CMR,
which potentially can change the hemodynamic state.
However, this is unavoidable since most pediatric
catheterization at our institution is performed under
general anesthesia. Anesthesia, on the other hand, is
avoided for CMR if possible for children over the age of
8 years and may be a better reflection of the cardiovas-
cular function of the subject at baseline. Two of the
subjects had greater than mild tricuspid regurgitation.
The additional volume from the tricuspid regurgitation
would impact the RVEDVi, and thus, also impact the
VVCRm. Moving forward, this factor must be teased
out in order to understand the impact of tricuspid re-
gurgitation in the progression of PH. The subject group
in this study is small and is a significant limitation to
the interpretation of this data. The data presented here
is a preliminary look at the feasibility of using CMR in
estimating VVCR in children with PH and to compare
this approach to a more standard approach using car-
diac catheterization. A larger subject population with
data collected from multiple pediatric centers would be
required to achieve adequate power. That, however,
does not negate the importance of the findings in this
study and is the stepping stone to posing the question
for clinicians: can serial catheterization in children with
PH be avoided if non-invasive imaging can provide ad-
equate cardiovascular data for the management of these
patients? And if so, this can potentially open the door
for facilitating research in a vulnerable population that
is unique from the adult population in whom the majority
of PH research has been done.
Conclusion
Measurement of VVCR by noninvasive means in pe-
diatrics is feasible. Pulmonary vascular non-reactivity may
contribute to ventricular-vascular decoupling in severe
PH. Therapeutic intervention to maintain a low vascular
afterload in reactive patients, may preserve right ventricu-
lar functional reserve and delay the onset of RV-PA de-
coupling. Use of VVCR may have significant prognostic
implication.
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